Sales Reps Slap Forest Labs With $100M Sex Bias Case

Law360, New York (July 5, 2012, 3:40 PM EDT) -- Four ex-sales representatives filed a $100 million putative class action against drug maker Forest Laboratories Inc. in New York on Thursday, claiming that female employees — particularly those who are pregnant or have children — get short shrift on compensation and promotions, attorneys for the plaintiffs said.

The suit, which targets Forest Laboratories and subsidiary Forest Pharmaceuticals Inc., is a proposed class action under Title VII and collective action under the Equal Pay Act. The complaint also includes non-class claims for sexual harassment, retaliation and violations...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.